Synergy CHC Corp. (SNYR)
1.87
+0.01
(+0.54%)
USD |
NASDAQ |
Jan 02, 16:00
1.87
0.00 (0.00%)
After-Hours: 20:00
Synergy CHC Cash from Investing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Acurx Pharmaceuticals, Inc. | 0.00 |
| NeOnc Technologies Holdings, Inc. | 0.00 |
| NRX Pharmaceuticals, Inc. | -2.561M |
| BioVie, Inc. | 0.00 |
| Lantern Pharma, Inc. | 5.928M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.309M |
| Cash from Financing (Quarterly) | 1.883M |
| Free Cash Flow | -6.635M |
| Free Cash Flow Per Share (Quarterly) | -0.2284 |
| Free Cash Flow to Equity (Quarterly) | -0.5487M |
| Free Cash Flow to Firm (Quarterly) | -1.032M |
| Free Cash Flow Yield | -39.25% |